News

Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...
President Donald Trump’s plans for 100% tariffs on computer chips that aren’t made in the U.S. are stoking confusion among ...
Coco Green, who works at Dallas nonprofit Youth 180, helps parents navigate teen substance use — something she faced ...